Aarivapharmapltd
Aarivapharmapltd is a Private Indian company incorporated in 2025 and based in Gujarat, India. Aarivapharmapltd operates in Pharmaceuticals & Chemicals (NIC 24230) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Aarivapharmapltd - Manufacturer of fine chemicals, bulk drugs, iodine, and citrate derivatives.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Aarivapharmapltd.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +31d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 22 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Aarivapharmapltd.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 915730977 | Kotak Mahindra Bank Ltd(Bank) | ₹17.74 Cr | 27 Jan 2021 | Open |
| 658237731 | Axis Bank Ltd(Bank) | ₹22.15 Cr | 27 Jan 2021 | Open |
| 132792493 | HDFC Bank Ltd(Bank) | ₹16.63 Cr | 12 Mar 2021 | Satisfied |
| 898961764 | ICICI Bank Ltd(Bank) | ₹22.16 Cr | 12 Mar 2023 | Satisfied |
| 672146311 | Axis Bank Ltd(Bank) | ₹16.04 Cr | 12 Mar 2023 | Satisfied |
| 426010052 | Kotak Mahindra Bank Ltd(Bank) | ₹5.28 Cr | 12 Mar 2023 | Open |
Charge IDs, lenders & amounts for Aarivapharmapltd.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹63.04 Cr | ₹8.13 Cr | ₹35.80 Cr | ₹71.99 Cr | 72 |
| FY2023-24 | ₹53.28 Cr | ₹5.72 Cr | ₹40.56 Cr | ₹89.09 Cr | 182 |
| FY2022-23 | ₹44.27 Cr | ₹4.59 Cr | ₹26.16 Cr | ₹68.88 Cr | 25 |
| FY2021-22 | ₹39.59 Cr | ₹4.31 Cr | ₹13.40 Cr | ₹36.03 Cr | 214 |
Audited financials & ratios for Aarivapharmapltd.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹63.04 Cr | ₹53.28 Cr | ₹44.27 Cr | ₹39.59 Cr |
| Other income | ₹2.48 Cr | ₹34.04 L | ₹1.35 Cr | ₹1.37 Cr |
| Total income | ₹65.52 Cr | ₹53.62 Cr | ₹45.62 Cr | ₹40.96 Cr |
| Total expenses | ₹55.12 Cr | ₹46.31 Cr | ₹39.74 Cr | ₹35.45 Cr |
| Profit before tax | ₹10.56 Cr | ₹7.43 Cr | ₹5.97 Cr | ₹5.60 Cr |
| Profit / (Loss) after tax | ₹8.13 Cr | ₹5.72 Cr | ₹4.59 Cr | ₹4.31 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹35.80 Cr | ₹40.56 Cr | ₹26.16 Cr | ₹13.40 Cr |
| Borrowings | ₹13.03 Cr | ₹17.87 Cr | ₹20.42 Cr | ₹12.21 Cr |
| Current liabilities | ₹17.94 Cr | ₹26.13 Cr | ₹18.50 Cr | ₹10.28 Cr |
| Total liabilities | ₹36.19 Cr | ₹48.52 Cr | ₹42.72 Cr | ₹22.63 Cr |
| Current assets | ₹39.87 Cr | ₹40.87 Cr | ₹26.39 Cr | ₹19.62 Cr |
| Cash & equivalents | ₹10.14 Cr | ₹5.51 Cr | ₹9.63 Cr | ₹2.69 Cr |
| Total assets | ₹71.99 Cr | ₹89.09 Cr | ₹68.88 Cr | ₹36.03 Cr |
| Employees | 72 | 182 | 25 | 214 |
Audited financials & ratios for Aarivapharmapltd.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹63.04 Cr | -3.1% | +4.6% | -0.5% |
| Profit after Tax | ₹8.13 Cr | +27.7% | -0.3% | +12.8% |
| Net Worth | ₹35.80 Cr | +0.8% | +17.6% | +11.3% |
| Employees | 72 | +14.5% | +8.4% | +7.7% |
Audited financials & ratios for Aarivapharmapltd.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹63.04 Cr | ₹8.13 Cr | +12.89% | +22.18% | +22.69% | +11.29% | 0.36 | ₹87.56 L |
| FY2023-24 | ₹53.28 Cr | ₹5.72 Cr | +10.73% | +6.68% | +14.09% | +6.42% | 0.44 | ₹29.28 L |
| FY2022-23 | ₹44.27 Cr | ₹4.59 Cr | +10.37% | +21.69% | +17.55% | +6.67% | 0.78 | ₹1.77 Cr |
| FY2021-22 | ₹39.59 Cr | ₹4.31 Cr | +10.87% | +12.33% | +32.13% | +11.95% | 0.91 | ₹18.50 L |
Audited financials & ratios for Aarivapharmapltd.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 2,43,87,247 | 55.95% |
| Institutional Investors | 1 | 86,17,536 | 19.77% |
| Public & Others | 40 | 1,05,84,026 | 24.28% |
Promoter, institutional & public holding for Aarivapharmapltd.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
118 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.